Health
OHDSI awarded $10 MM FDA contract to monitor safety/effectiveness of vaccines, biologics – EurekAlert
A team of observational health data researchers, coordinated by Columbia University, will support an FDA program to conduct safety and effectiveness surveillance…
NEW YORK, NY (Dec. 1, 2020)–Researchers within the Observational Health Data Services and Informatics (OHDSI) community were recently awarded a $10 million contract from the U.S. Food and Drug Administration (FDA) to provide support to the Biologics Effectiveness and Safety (BEST) program, which was launched by the FDA Center for Biologics Evaluation and Research (CBER) in 2017.
The lead research team, primarily comprised of OHDSI personnel from Columbia University, UCLA, and Northeastern University,…
-
Business19 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
Noosa News20 hours agoBroncos staffer who guided Mam through crash crisis admits to drink-driving
-
Noosa News21 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal
-
Noosa News14 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track